Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIP13 | Q15645 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124680 | 0.88 | ELANE (0.38) | CACNA1BAPBA1 | |
| SCHEMBL13050166 | 0.85 | TRIP13 (0.38) | TRIP13MGLLFAAHAR | |
| SCHEMBL10124704 | 0.82 | TRIP13 (0.33) | TRIP13CACNA1BAPBA1MGLLFAAH | |
| SCHEMBL10124681 | 0.80 | ELANE (0.38) | — | |
| SCHEMBL10124682 | 0.80 | ELANE (0.38) | — | |
| SCHEMBL10124677 | 0.79 | ELANE (0.39) | CACNA1BAPBA1 | |
| SCHEMBL10124675 | 0.72 | ELANE (0.36) | CACNA1BAPBA1AR | |
| SCHEMBL10124695 | 0.70 | ELANE (0.33) | CACNA1BAPBA1 | |
| SCHEMBL18697264 | 0.70 | ELANE (0.35) | CACNA1BAPBA1MGLLAR | |
| SCHEMBL10124673 | 0.69 | POLB (0.41) | TRIP13MGLLFAAHAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9045480-B2 | Sterically hindered amine light stabilizers | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | AAAS, CRY1, TAAR1 | TRIP13 799/4885CACNA1B 4469/4885APBA1 3485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.